Tesai Care

heecap.com ↗ ·Barcelona ·Seed

Tesai Care is a Barcelona-based medtech startup developing heecap, a non-invasive transcutaneous electrostimulation device (TERM) that activates the inspiratory and expiratory muscles in sync with a patient's breathing to prevent and treat respiratory muscle atrophy in mechanically ventilated ICU patients. A deeptech spin-off of Vall d'Hebron Research Institute (VHIR) and Parc Taulí's I3PT, it raised a ~€2.8M seed round in December 2024 led by Nara Capital and is running clinical validation (NCT07363902) with the aim of obtaining CE marking as a medical device. It is headquartered in Barcelona (Pier07, Via Laietana 26).

Founded

2021

Founders

Total funds raised

€2.8M

SectorsHealthtech & Bio, Medical Devices, Deeptech & Hardware, Digital Health Start-up MapHealthtech & Bio › Medical devices & surgical hardware

Suggest a correction

Founders

Laura Lizama

CEO & Co-founder

Sofía Ferreira

CTO & Co-founder

Global models 3

Lungpacer Medical

United States · lungpacer.com ↗

Medical device that stimulates the diaphragm through the phrenic nerves to prevent respiratory muscle wasting and help wean ICU patients off mechanical ventilation, sold to hospitals.

$120MComparable

Stimdia Medical

United States · stimdia.com ↗

Percutaneous phrenic nerve stimulation device that keeps the diaphragm working in ventilated ICU patients to speed weaning, aiming at regulatory clearance and hospital sales.

$20MComparable

Liberate Medical

United States · liberatemedical.com ↗

Non-invasive VentFree system that electrically stimulates the abdominal muscles in time with breathing in ventilated patients to reduce ventilation time, the closest match to heecap.

$10MComparable

In the same niche 72 others

See all in the Start-ups Map →

Anaconda Biomed

Sant Cugat del Vallès

Series C · €90.1M

INBRAIN Neuroelectronics

Venture Debt · €71.2M

Medlumics

Madrid

No stage disclosed · €57.8M

+66 more →

Notes: Most funded first

Investors 4

Open as list →

Centro para el Desarrollo Tecnológico y la Innovación

www.cdti.es

Seed 2024 Spain

Institut Català de Finances

Women TechEU

Investor European Union

Funding rounds 1

·1 not counted

Date	Round	Amount	Lead
2024-12-09	Seed (estimated)	€2.77M incl. debt: equity and debt, the split was not disclosed	Lead not disclosed +3 more

Not counted (1)

Not counted in totals

2024-12-09 Public Loan — ENISA

News 4

Open as list →

Published	Article
2026-10-23	Nanogrow gana el VDS 2026 con sus medicamentos basados en nanoanticuerpos ↗ Emprendedores 2026-10-23
2024-12-16	Tesai Care closes a €2.8M round with the participation of Nara Capital, CDTI Innvierte, ICF, ENISA, among others, to prevent muscular atrophy ↗ Capital-Riesgo +1 source 2 reportsfirst 2024-12-16 Tesai Care closes a €2.8M round with the participation of Nara Capital, CDTI Innvierte, ICF, ENISA, among others, to prevent muscular atrophyCapital-Riesgo · 2024-12-16↗ Tesai Care cierra una ronda de €2,8M con la participación de Nara Capital, CDTI Innvierte, ICF, ENISA, entre otros, para prevenir la atrofia muscularCapital-Riesgo.es · 2024-12-16↗ 2024-12-16
2024-12-09	Tesai Care launches a pioneering clinical trial with heecap to prevent respiratory muscle atrophy in mechanically ventilated patients ↗ Biotech Spain 2024-12-09
2024-09-26	InnoStars Awards 2024: Forty start-ups set to change healthcare in Central, Eastern, and Southern Europe ↗ EIT Health 2024-09-26